Back to top

RBC Capital Keeps Their Hold Rating on Prothena (PRTA)

RBC Capital analyst Brian Abrahams maintained a Hold rating on Prothena yesterday and set a price target of $13.00. The company’s shares closed yes...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Prothena Corporation plc (PRTA)